Loading...
Header Logo
Keywords
Last Name
Institution
 Back to Profile

Andrew Frelinger

Concepts (375)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Platelet Activation
38
2016
131
6.650
 Why?
Blood Platelets
52
2016
238
6.650
 Why?
Platelet Aggregation Inhibitors
32
2016
227
6.180
 Why?
Platelet Aggregation
26
2016
107
3.800
 Why?
Ticlopidine
17
2015
82
3.620
 Why?
Piperazines
13
2013
103
3.170
 Why?
Adenosine Diphosphate
18
2016
67
2.700
 Why?
Aspirin
13
2016
160
2.640
 Why?
Platelet Function Tests
18
2016
54
2.400
 Why?
Thiophenes
11
2013
43
1.950
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
17
2015
73
1.940
 Why?
Dinucleoside Phosphates
5
2016
35
1.940
 Why?
Anemia, Sickle Cell
5
2014
42
1.610
 Why?
Drug Resistance
5
2009
79
1.230
 Why?
Antibodies, Monoclonal
17
2013
685
1.140
 Why?
Cardiovascular Diseases
8
2015
560
1.140
 Why?
Immunoglobulin Fab Fragments
8
2013
45
1.110
 Why?
2-Pyridinylmethylsulfinylbenzimidazoles
2
2013
5
1.100
 Why?
Purpura, Thrombocytopenic, Idiopathic
4
2015
19
1.060
 Why?
Humans
82
2017
34160
0.940
 Why?
Flow Cytometry
19
2015
615
0.930
 Why?
Platelet Count
5
2015
40
0.920
 Why?
P-Selectin
13
2015
48
0.910
 Why?
Thromboxane B2
3
2015
17
0.870
 Why?
Coronary Artery Disease
6
2014
248
0.820
 Why?
Cyclooxygenase 1
2
2009
11
0.810
 Why?
Male
44
2017
17242
0.790
 Why?
Platelet Adhesiveness
8
2016
22
0.760
 Why?
Middle Aged
33
2015
9874
0.750
 Why?
Female
43
2017
18881
0.740
 Why?
Platelet-Rich Plasma
2
2015
7
0.710
 Why?
Hemorrhage
4
2015
162
0.690
 Why?
Epidermal Growth Factor
2
2015
51
0.690
 Why?
Electricity
1
2015
6
0.670
 Why?
Proton Pump Inhibitors
2
2013
20
0.660
 Why?
Adult
26
2017
9698
0.650
 Why?
Leukocytes
7
2014
107
0.610
 Why?
Cytoplasmic Granules
2
2015
52
0.610
 Why?
Platelet Membrane Glycoproteins
12
2016
26
0.590
 Why?
Blood Coagulation
6
2016
35
0.570
 Why?
Polymorphism, Genetic
2
2017
168
0.570
 Why?
Peptides
4
2013
418
0.550
 Why?
Omeprazole
1
2012
7
0.530
 Why?
Dose-Response Relationship, Drug
10
2016
694
0.530
 Why?
CD40 Ligand
6
2015
176
0.500
 Why?
Case-Control Studies
9
2017
660
0.450
 Why?
Cross-Over Studies
5
2013
106
0.440
 Why?
Acute Coronary Syndrome
4
2014
174
0.440
 Why?
Fibrinogen
7
2006
37
0.430
 Why?
Thrombin
7
2015
54
0.420
 Why?
Double-Blind Method
8
2014
489
0.410
 Why?
Pyrazoles
3
2015
43
0.400
 Why?
Young Adult
10
2016
2167
0.400
 Why?
Clot Retraction
1
2007
3
0.400
 Why?
Blood Coagulation Factors
1
2007
14
0.390
 Why?
Prodrugs
1
2007
17
0.390
 Why?
Fibrinolytic Agents
4
2016
154
0.380
 Why?
Arachidonic Acid
3
2006
45
0.380
 Why?
Microfilament Proteins
5
2013
83
0.370
 Why?
Coronary Thrombosis
3
2016
21
0.370
 Why?
Cyclooxygenase 2
1
2006
54
0.350
 Why?
Tyrosine
2
2003
82
0.340
 Why?
Aryl Hydrocarbon Hydroxylases
4
2013
16
0.340
 Why?
Cell-Derived Microparticles
2
2015
6
0.330
 Why?
Aged
14
2015
7641
0.320
 Why?
Cell Adhesion Molecules
4
2013
70
0.320
 Why?
Treatment Outcome
8
2015
2667
0.320
 Why?
Electric Stimulation
2
2015
108
0.310
 Why?
Platelet Glycoprotein GPIb-IX Complex
4
2015
11
0.310
 Why?
Thrombocytopenia
3
2015
41
0.310
 Why?
Hydrazines
2
2015
10
0.300
 Why?
Benzoates
2
2015
17
0.300
 Why?
Hypothermia, Induced
1
2003
22
0.290
 Why?
Phosphoproteins
4
2013
185
0.290
 Why?
Area Under Curve
2
2013
79
0.270
 Why?
Drug Interactions
2
2013
95
0.270
 Why?
Myelodysplastic Syndromes
2
2013
43
0.270
 Why?
Annexin A5
2
2015
26
0.260
 Why?
Leukemia, Myeloid, Acute
2
2013
86
0.260
 Why?
Collagen
5
2009
119
0.260
 Why?
Monocytes
5
2007
299
0.250
 Why?
Drug Therapy, Combination
2
2013
344
0.250
 Why?
Enzyme-Linked Immunosorbent Assay
5
2015
402
0.250
 Why?
Adolescent
7
2015
4025
0.250
 Why?
Predictive Value of Tests
5
2015
697
0.250
 Why?
Time Factors
7
2016
2605
0.250
 Why?
Blood Platelet Disorders
2
2015
7
0.240
 Why?
Peptide Fragments
4
2015
292
0.240
 Why?
Receptors, Thrombin
2
2015
6
0.240
 Why?
Thrombosis
4
2016
150
0.230
 Why?
Diabetic Nephropathies
2
2010
25
0.230
 Why?
Drug Administration Schedule
2
2012
226
0.210
 Why?
Cell Differentiation
2
2015
1046
0.210
 Why?
Dogs
6
2016
239
0.210
 Why?
Reference Values
2
2012
305
0.210
 Why?
Animals
15
2016
14706
0.200
 Why?
Cattle
3
2015
275
0.200
 Why?
Neutrophils
4
2008
265
0.200
 Why?
Asphyxia
1
2017
5
0.190
 Why?
Sudden Infant Death
1
2017
10
0.190
 Why?
Receptor, PAR-1
2
2015
9
0.190
 Why?
Serotonin
1
2017
66
0.180
 Why?
Light
2
2015
187
0.180
 Why?
Myocardial Infarction
3
2009
728
0.180
 Why?
Prospective Studies
5
2014
1668
0.180
 Why?
Phosphorylation
3
2013
672
0.170
 Why?
Wiskott-Aldrich Syndrome
1
2015
7
0.170
 Why?
Octoxynol
1
2015
9
0.170
 Why?
Drug Evaluation, Preclinical
1
2015
62
0.170
 Why?
Factor V
2
2008
6
0.170
 Why?
Genetic Diseases, X-Linked
1
2015
15
0.170
 Why?
Scattering, Radiation
1
2015
64
0.170
 Why?
Drug Stability
1
2015
102
0.170
 Why?
Chromatography, Liquid
1
2015
65
0.170
 Why?
Diabetes Mellitus, Type 1
2
2010
486
0.160
 Why?
Cystic Fibrosis
2
2007
95
0.160
 Why?
Tandem Mass Spectrometry
1
2015
68
0.160
 Why?
Structure-Activity Relationship
1
2015
263
0.160
 Why?
Phosphatidylserines
2
2007
18
0.160
 Why?
Child, Preschool
2
2015
1311
0.160
 Why?
Vascular Patency
3
2009
98
0.160
 Why?
Cell Proliferation
2
2015
667
0.160
 Why?
Cross-Sectional Studies
2
2015
1197
0.150
 Why?
Drug Monitoring
2
2013
96
0.150
 Why?
Stereoisomerism
1
2014
44
0.150
 Why?
Chest Pain
1
2014
36
0.150
 Why?
Kinetics
3
2007
709
0.150
 Why?
Cell Separation
2
2005
133
0.150
 Why?
Receptors, Aryl Hydrocarbon
1
2013
9
0.140
 Why?
Myeloproliferative Disorders
1
2013
20
0.140
 Why?
Epithelial Cells
1
2015
248
0.140
 Why?
Hematologic Neoplasms
1
2013
16
0.140
 Why?
Child
3
2015
2648
0.140
 Why?
P-Glycoproteins
1
2013
6
0.140
 Why?
P-Glycoprotein
1
2013
13
0.140
 Why?
Coronary Disease
3
2005
359
0.140
 Why?
Confounding Factors (Epidemiology)
1
2013
59
0.140
 Why?
Aryldialkylphosphatase
1
2013
20
0.140
 Why?
Gene Expression
1
2015
611
0.140
 Why?
Cell Adhesion
2
2003
205
0.130
 Why?
Thrombelastography
2
2011
4
0.130
 Why?
Hematopoietic Stem Cells
1
2013
211
0.130
 Why?
Rats
1
2015
1762
0.130
 Why?
Neoplasm Proteins
1
2013
225
0.130
 Why?
Platelet Activating Factor
1
2011
5
0.130
 Why?
Confidence Intervals
1
2012
244
0.130
 Why?
Thromboxane A2
2
2008
7
0.130
 Why?
Platelet Transfusion
1
2011
12
0.130
 Why?
Heterozygote
2
2011
117
0.120
 Why?
Diabetic Angiopathies
1
2011
27
0.120
 Why?
Thromboplastin
2
2007
8
0.120
 Why?
Genotype
4
2017
480
0.120
 Why?
Sleep Apnea, Obstructive
1
2011
27
0.120
 Why?
Cell Line
1
2015
1755
0.120
 Why?
Pain
1
2013
222
0.120
 Why?
Patient Compliance
1
2013
295
0.120
 Why?
Withholding Treatment
1
2010
33
0.120
 Why?
Emergency Service, Hospital
1
2014
363
0.110
 Why?
Serotonin Antagonists
1
2009
12
0.110
 Why?
Benzamides
1
2009
44
0.110
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
2
2007
72
0.110
 Why?
Morpholines
1
2009
57
0.110
 Why?
Protein Binding
3
2002
1223
0.110
 Why?
Epitopes
3
1992
240
0.110
 Why?
Inflammation
4
2007
666
0.110
 Why?
Recurrence
2
2009
402
0.110
 Why?
Factor Va
1
2008
2
0.110
 Why?
Circadian Rhythm
1
2011
268
0.110
 Why?
Cyclooxygenase Inhibitors
1
2008
31
0.100
 Why?
Receptors, Peptide
1
1988
24
0.100
 Why?
Kidney Failure, Chronic
1
2010
148
0.100
 Why?
Biotransformation
1
2007
13
0.100
 Why?
Receptors, Adenosine A2
1
2007
5
0.100
 Why?
Receptors, Immunologic
1
1988
155
0.100
 Why?
Calcium
2
2007
503
0.100
 Why?
Oligopeptides
4
1993
98
0.100
 Why?
Blood Cells
1
2007
24
0.100
 Why?
Smoking
1
2013
756
0.090
 Why?
Laboratories
1
2007
20
0.090
 Why?
Leukocytes, Mononuclear
1
2008
214
0.090
 Why?
Thrombolytic Therapy
1
2007
142
0.090
 Why?
Myocardial Reperfusion Injury
1
2006
19
0.090
 Why?
Ischemic Preconditioning, Myocardial
1
2006
23
0.090
 Why?
Bayes Theorem
1
2006
47
0.090
 Why?
Models, Cardiovascular
1
2006
56
0.090
 Why?
Treatment Refusal
1
2006
53
0.090
 Why?
Diabetes Mellitus, Type 2
1
2011
420
0.090
 Why?
Up-Regulation
1
2007
322
0.090
 Why?
Sensitivity and Specificity
1
2008
780
0.090
 Why?
Endothelium
2
2003
17
0.090
 Why?
Phenotype
4
2015
803
0.080
 Why?
Dalteparin
2
2003
6
0.080
 Why?
Cells, Cultured
2
2007
1799
0.080
 Why?
Tissue Fixation
2
2001
18
0.080
 Why?
Heparin
2
2003
101
0.080
 Why?
Multivariate Analysis
1
2006
724
0.080
 Why?
Hemostasis
2
2016
15
0.070
 Why?
Protein Conformation
2
2001
600
0.070
 Why?
Obesity
1
2011
871
0.070
 Why?
Crotalid Venoms
2
1993
2
0.070
 Why?
Infant
2
2017
951
0.070
 Why?
Binding, Competitive
2
2001
95
0.070
 Why?
Disease Models, Animal
4
2016
1190
0.070
 Why?
Severity of Illness Index
1
2006
893
0.070
 Why?
Hemostatics
1
2003
23
0.070
 Why?
Angina, Unstable
1
2003
69
0.070
 Why?
Risk Factors
3
2017
3030
0.070
 Why?
Signal Transduction
2
2016
2304
0.070
 Why?
Pharmacogenetics
2
2012
19
0.070
 Why?
Drug Synergism
1
2002
104
0.070
 Why?
Venous Thrombosis
1
2003
94
0.070
 Why?
Hirudins
1
2001
8
0.060
 Why?
Immunophenotyping
1
2002
167
0.060
 Why?
Epinephrine
3
2008
45
0.060
 Why?
Integrins
2
1993
99
0.060
 Why?
Image Cytometry
1
2001
1
0.060
 Why?
Cell Division
1
2003
431
0.060
 Why?
Infant, Newborn
3
2011
730
0.060
 Why?
Microscopy, Confocal
1
2001
191
0.060
 Why?
Antigens, CD
1
2001
292
0.060
 Why?
Endothelium, Vascular
1
2001
186
0.060
 Why?
Follow-Up Studies
2
2014
1543
0.050
 Why?
Amino Acid Sequence
6
1992
1491
0.050
 Why?
Thrombasthenia
4
2004
7
0.050
 Why?
Molecular Sequence Data
6
1992
2049
0.050
 Why?
Coronary Circulation
2
2009
68
0.050
 Why?
Hydroxyindoleacetic Acid
1
2017
12
0.050
 Why?
Autopsy
1
2017
26
0.050
 Why?
Tetradecanoylphorbol Acetate
2
2001
65
0.050
 Why?
Serotonin Plasma Membrane Transport Proteins
1
2017
23
0.050
 Why?
Brain Stem
1
2017
29
0.050
 Why?
Binding Sites
4
1993
749
0.050
 Why?
Chromatography, High Pressure Liquid
1
2017
165
0.050
 Why?
Edetic Acid
2
2004
18
0.050
 Why?
Randomized Controlled Trials as Topic
2
2012
344
0.040
 Why?
Adenosine Monophosphate
1
2016
16
0.040
 Why?
Receptors, Thrombopoietin
1
2015
9
0.040
 Why?
Integrin beta3
2
2008
6
0.040
 Why?
Heredity
1
2015
4
0.040
 Why?
Alleles
2
2013
308
0.040
 Why?
Exocytosis
1
2015
67
0.040
 Why?
Polymerase Chain Reaction
2
2013
452
0.040
 Why?
Platelet-Derived Growth Factor
1
2014
20
0.040
 Why?
Rats, Sprague-Dawley
1
2016
475
0.040
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2007
152
0.040
 Why?
Temperature
2
2011
249
0.040
 Why?
Carotid Artery Thrombosis
1
1993
5
0.040
 Why?
Transforming Growth Factor beta
1
2014
140
0.040
 Why?
Erythroid Cells
1
2013
4
0.040
 Why?
Janus Kinase 2
1
2013
12
0.040
 Why?
Ligands
2
1991
337
0.040
 Why?
Carbazoles
1
2013
16
0.040
 Why?
Megakaryocytes
1
2013
22
0.040
 Why?
Leukocyte Count
1
2013
81
0.040
 Why?
Cohort Studies
1
2017
1417
0.040
 Why?
Induced Pluripotent Stem Cells
1
2013
36
0.040
 Why?
Gene Expression Regulation, Enzymologic
1
2013
118
0.030
 Why?
Amino Acid Substitution
1
2013
209
0.030
 Why?
Mutation, Missense
1
2013
120
0.030
 Why?
Cell Lineage
1
2013
204
0.030
 Why?
Genetic Predisposition to Disease
1
2015
456
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2012
12
0.030
 Why?
Clinical Trials, Phase III as Topic
1
2012
13
0.030
 Why?
Genome, Human
1
2013
141
0.030
 Why?
Reproducibility of Results
1
2015
977
0.030
 Why?
Cell Shape
1
2011
15
0.030
 Why?
Cardiovascular System
1
2011
15
0.030
 Why?
Fibronectins
1
1991
36
0.030
 Why?
Homozygote
1
2011
103
0.030
 Why?
Body Temperature
1
2011
46
0.030
 Why?
Behavior
1
2011
37
0.030
 Why?
Bleeding Time
1
2011
7
0.030
 Why?
Pilot Projects
1
2013
497
0.030
 Why?
Chymotrypsin
1
1991
31
0.030
 Why?
Hematocrit
1
2011
39
0.030
 Why?
Polysomnography
1
2011
31
0.030
 Why?
Fetal Blood
1
2011
62
0.030
 Why?
Blood Coagulation Disorders
1
1990
12
0.030
 Why?
Models, Biological
1
2016
979
0.030
 Why?
Statistics, Nonparametric
1
2011
175
0.030
 Why?
Denmark
1
2010
10
0.030
 Why?
Kidney Function Tests
1
2010
21
0.030
 Why?
Drug Inverse Agonism
1
2009
2
0.030
 Why?
Chi-Square Distribution
1
2011
366
0.030
 Why?
Receptor, Serotonin, 5-HT2A
1
2009
12
0.030
 Why?
Prognosis
1
2013
937
0.030
 Why?
Glomerular Filtration Rate
1
2010
62
0.030
 Why?
Blood Pressure
1
2011
372
0.030
 Why?
Infant, Extremely Low Birth Weight
1
2008
3
0.030
 Why?
Hemodynamics
1
2009
170
0.030
 Why?
Cations, Divalent
1
1988
18
0.030
 Why?
Stress, Psychological
1
2011
267
0.030
 Why?
Survival Rate
1
2010
489
0.030
 Why?
Blotting, Western
2
2005
538
0.030
 Why?
Kidney
1
2010
280
0.020
 Why?
Disease Progression
1
2010
479
0.020
 Why?
Apoptosis
1
2013
868
0.020
 Why?
Phenethylamines
1
2007
12
0.020
 Why?
Body Mass Index
1
2011
718
0.020
 Why?
Antigens, CD14
1
2008
150
0.020
 Why?
Cell Membrane
2
2005
418
0.020
 Why?
Adenosine
1
2007
73
0.020
 Why?
Combined Modality Therapy
1
2007
264
0.020
 Why?
Species Specificity
1
2007
298
0.020
 Why?
Exercise
1
2011
518
0.020
 Why?
Blood Flow Velocity
1
2006
55
0.020
 Why?
Random Allocation
1
2006
166
0.020
 Why?
Coronary Vessels
1
2006
95
0.020
 Why?
Factor Xa
1
2005
3
0.020
 Why?
Antigens, CD11b
1
2005
15
0.020
 Why?
Cell Aggregation
1
2005
21
0.020
 Why?
Macrophage-1 Antigen
1
2005
29
0.020
 Why?
Age Factors
1
2008
1100
0.020
 Why?
Alprostadil
1
2005
9
0.020
 Why?
Mutation
1
1992
1738
0.020
 Why?
Ibuprofen
1
2005
15
0.020
 Why?
Cell Communication
1
2005
99
0.020
 Why?
Aged, 80 and over
1
2012
2864
0.020
 Why?
Cyclic AMP
1
2005
124
0.020
 Why?
Actin Depolymerizing Factors
1
2004
2
0.020
 Why?
Destrin
1
2004
2
0.020
 Why?
Nucleic Acid Synthesis Inhibitors
1
2004
13
0.020
 Why?
Cytochalasin D
1
2004
20
0.020
 Why?
Vitamin E
1
2005
54
0.020
 Why?
Syndrome
1
2004
125
0.020
 Why?
Matrix Metalloproteinases
1
2004
16
0.020
 Why?
Chelating Agents
1
2004
34
0.020
 Why?
Dipeptides
1
2004
31
0.020
 Why?
Fatty Acids
1
2005
134
0.020
 Why?
Protease Inhibitors
1
2004
55
0.020
 Why?
Solubility
1
2004
147
0.020
 Why?
Methods
1
2003
46
0.020
 Why?
Blood
1
2003
27
0.020
 Why?
Acute Disease
1
2005
529
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
530
0.020
 Why?
Infusions, Intravenous
1
2003
143
0.020
 Why?
Saphenous Vein
1
2003
49
0.020
 Why?
Atherectomy
1
2001
3
0.020
 Why?
Specimen Handling
1
2002
30
0.020
 Why?
Creatine Kinase, MB Form
1
2001
12
0.020
 Why?
Creatine Kinase
1
2001
41
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2004
489
0.020
 Why?
Mice
1
2013
7381
0.020
 Why?
Isoenzymes
1
2001
131
0.020
 Why?
Antibodies, Blocking
1
2001
35
0.020
 Why?
Drug Combinations
1
2001
103
0.020
 Why?
Glycoproteins
1
2002
158
0.010
 Why?
Anticoagulants
1
2003
217
0.010
 Why?
Immunohistochemistry
1
2003
774
0.010
 Why?
Platelet Storage Pool Deficiency
1
2000
1
0.010
 Why?
Blood Specimen Collection
1
2000
21
0.010
 Why?
Blood Banks
1
2000
8
0.010
 Why?
Quality Control
1
2000
47
0.010
 Why?
Calibration
1
2000
48
0.010
 Why?
Recombinant Proteins
2
1992
612
0.010
 Why?
RNA, Messenger
1
2005
1255
0.010
 Why?
Brain Ischemia
1
2000
198
0.010
 Why?
Base Sequence
2
1992
1245
0.010
 Why?
DNA
2
1992
608
0.010
 Why?
Membrane Proteins
1
2000
650
0.010
 Why?
Fluorescent Antibody Technique
1
1993
228
0.010
 Why?
Chromatography, Affinity
1
1992
43
0.010
 Why?
CHO Cells
1
1992
186
0.010
 Why?
DNA Mutational Analysis
1
1992
148
0.010
 Why?
Amino Acids
1
1992
95
0.010
 Why?
Hydrolysis
1
1991
104
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
1991
160
0.010
 Why?
Mutagenesis, Site-Directed
1
1992
247
0.010
 Why?
Microscopy, Fluorescence
1
1993
362
0.010
 Why?
Primary Myelofibrosis
1
1990
4
0.010
 Why?
Cricetinae
1
1992
401
0.010
 Why?
Pancreas
1
1991
111
0.010
 Why?
RNA
1
1992
284
0.010
 Why?
Genetic Variation
1
1990
255
0.010
 Why?
Recombinant Fusion Proteins
1
1987
477
0.010
 Why?
Frelinger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (375) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department